Our pipeline includes a CTLA-4 antibody at the advanced pre-clinical stage and we promote additional immune-therapy antibodies which are at an earlier pre-clinical stage:

Immune Oncology

Clinical Indications:
Metastatic melanoma

Immune Oncology

Tikcro develops its drug candidates in collaboration with research centers and pharmaceutical contracting partners.

Our strategy is to establish product development, pre-clinical and discovery collaborations. These collaborations supplement our corporate and business capabilities, to advance our pipeline and validate our technology.

Product in Development


Antibodies for immune modulators

December 2014

© Copyright 2015, Tikcro Ltd. | Legal - Terms of use | All rights reserved | Site by Imaginet